Nomogram to predict postoperative complications after cytoreductive surgery for advanced epithelial ovarian cancer: A multicenter retrospective cohort study

Nomogram to predict postoperative complications after cytoreductive surgery for advanced epithelial ovarian cancer: A multicenter retrospective cohort study

ObjectiveTo establish nomograms to predict the risk of postoperative complications following cytoreductive surgery in patients with advanced epithelial ovarian cancer (AEOC).MethodsA multicenter retrospective cohort study that included patients with FIGO stage IIIC-IV epithelial ovarian cancer who u...

Full description

Bibliographic Details
Main Authors:	Caixia Jiang, Yingwei Liu, Junying Tang, Zhengyu Li, Wenjiao Min
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-11-01
Series:	Frontiers in Oncology
Subjects:	advanced epithelial ovarian cancer postoperative complications cytoreductive surgery nomogram predict
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2022.1052628/full

Similar Items

Splenectomy during cytoreductive surgery in epithelial ovarian cancer
by: Sun H, et al.
Published: (2018-09-01)

Cytoreductive surgery including distal pancreatectomy with splenectomy in advanced stage ovarian cancer: Two centers analysis
by: Anil Erturk, et al.
Published: (2020-11-01)

The role of CA-125, GLS and FASN in predicting cytoreduction for epithelial ovarian cancers
by: G. N. A. Winarno, et al.
Published: (2020-07-01)

Prognostic Significance of Preoperative NLR, MLR, and PLR Values in Predicting the Outcome of Primary Cytoreductive Surgery in Serous Epithelial Ovarian Cancer
by: Anna Rebeka Kovács, et al.
Published: (2023-07-01)

When we open and close: Postoperative outcomes after aborted primary cytoreduction for ovarian cancer
by: Connor C. Wang, et al.
Published: (2022-06-01)

Significance of cholecystectomy in cytoreductive surgery for advanced ovarian cancer
by: Joo-Hyuk Son, et al.
Published: (2023-03-01)

Optimal cytoreduction for advanced epithelial ovarian cancer
by: N. G. Kormosh, et al.
Published: (2014-08-01)

The rate and role of diaphragmatic peritonectomy in optimal cytoreduction in patients with advanced stage ovarian cancer: a prospective study of 100 patients
by: Tomas Lūža, et al.
Published: (2014-04-01)

A Practical Nomogram to Predict Early Death in Advanced Epithelial Ovarian Cancer
by: Zixuan Song, et al.
Published: (2021-03-01)

Postoperative pulmonary complications and outcomes in cytoreductive surgery for ovarian cancer: a propensity-matched analysis
by: Mengmeng Xu, et al.
Published: (2022-04-01)

Improved prognosis for recurrent epithelial ovarian cancer by early diagnosis and 125I seeds implantation during suboptimal secondary cytoreductive surgery: a case report and literature review
by: Lin Xiao, et al.
Published: (2020-11-01)

Quaternary and beyond cytoreduction: An updated and expanded analysis
by: Beryl L. Manning-Geist, et al.
Published: (2021-08-01)

Hepatic Hilar Lymph Node Resection in Cytoreductive Surgery for Advanced Ovarian Cancer: A Necessity or Not?
by: Huang H, et al.
Published: (2021-10-01)

Clinical Utility of Preoperative Assessment in Ovarian Cancer Cytoreduction
by: Pratistha Koirala, et al.
Published: (2020-08-01)

Assessment of the American College of Surgeons Surgical Risk Calculator (ACS-SRC) for Prediction of Early Postoperative Complications in Patients Undergoing Cytoreductive Surgery for Ovarian Peritoneal Carcinomatosis
by: Cedric Kabeya, et al.
Published: (2024-12-01)

Prediction of suboptimal cytoreductive surgery in patients with advanced ovarian cancer based on preoperative and intraoperative determination of the peritoneal carcinomatosis index
by: Antoni Llueca, et al.
Published: (2018-02-01)

Epithelial ovarian cancer: Review article
by: Suchetha Sambasivan
Published: (2022-01-01)

Factors associated with surgical morbidity of primary debulking in epithelial ovarian cancer
by: Emre Günakan, et al.
Published: (2020-01-01)

Extended upper abdominal resections as part of debulking surgery at the time of tertiary cytoreduction for relapsed ovarian cancer; case report and literature review
by: Nicolae Bacalbașa, et al.
Published: (2017-11-01)

Pancreaticoduodenectomy in optimal primary cytoreduction of epithelial ovarian cancer: A case report and review of the literature
by: Joy M. Beissel, et al.
Published: (2014-12-01)

Role of reactive thrombocytosis after primary cytoreductive surgery in advanced ovarian cancer
by: Myeong-Seon Kim, et al.
Published: (2022-09-01)

Chemokine Ligand 5 to Predict Optimal Cytoreduction in Ovarian Cancer
by: Hidayat YM, et al.
Published: (2020-11-01)

Development and validation of radiomics nomogram for metastatic status of epithelial ovarian cancer
by: Yinping Leng, et al.
Published: (2024-05-01)

Microbiological monitoring in patients with advanced ovarian cancer before and after cytoreductive surgery – a preliminary report
by: Szymankiewicz Maria, et al.
Published: (2017-12-01)

Cytoreductive HIPEC-Combined Surgery in Treatment of Advanced Ovarian Cancer
by: M. V. Zabelin, et al.
Published: (2022-06-01)

Risk predictors of early recurrence in women with epithelial ovarian cancer in Lagos, Nigeria
by: Kehinde Sharafadeen Okunade, et al.
Published: (2020-08-01)

Interval between secondary cytoreductive surgery and adjuvant chemotherapy is not associated with survivals in patients with recurrent ovarian cancer
by: Soo Young Jeong, et al.
Published: (2019-12-01)

Front-line chemoimmunotherapy for treating epithelial ovarian cancer: Part II promising results of phase 2 study of paclitaxel-carboplatin-oregovomab regimen
by: Szu-Ting Yang, et al.
Published: (2024-01-01)

Advances in Cytoreductive Surgery and Combination Therapy for Ovarian Cancer
by: Xiaolan Lv, et al.
Published: (2022-07-01)

Some Aspects of Postoperative Management of Patients with Ovarian Cancer after Cytoreductive Surgery Using Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
by: D. D. Morikov, et al.
Published: (2022-05-01)

CA-125–indicated asymptomatic relapse confers survival benefit to ovarian cancer patients who underwent secondary cytoreduction surgery
by: Wang Fang, et al.
Published: (2013-02-01)

Is Optimal Cytoreduction Post Neoadjuvant Chemotherapy the Only Prognostic Factor in Advanced Ovarian Cancer?
by: Pravesh Dhiman, et al.
Published: (2022-07-01)

Is Optimal Cytoreduction Post Neoadjuvant Chemotherapy the Only Prognostic Factor in Advanced Ovarian Cancer?
by: Pravesh Dhiman, et al.
Published: (2022-07-01)

Optimal cytoreductive surgery in patients with disseminated ovarian cancer (the department’s experience)
by: N. G. Kormosh, et al.
Published: (2014-07-01)

Survival and Chemosensitivity in Advanced High Grade Serous Epithelial Ovarian Cancer Patients with and without a BRCA Germline Mutation: More Evidence for Shifting the Paradigm towards Complete Surgical Cytoreduction
by: Diederick De Jong, et al.
Published: (2022-11-01)

Prediction Models for Complete Resection in Secondary Cytoreductive Surgery of Patients With Recurrent Ovarian Cancer
by: Caixia Jiang, et al.
Published: (2021-09-01)

Explaining the Elusive Nature of a Well-Defined Threshold for Blood Transfusion in Advanced Epithelial Ovarian Cancer Cytoreductive Surgery
by: Alexandros Laios, et al.
Published: (2023-12-01)

Surgical outcomes of ureteral reconstruction during cytoreductive surgery for ovarian cancer: a retrospective cohort study
by: Ji Hyun Kim, et al.
Published: (2022-11-01)

Hyperthermic Intraperitoneal Chemotherapy and Cytoreductive Surgery in Ovarian Cancer: An Umbrella Review of Meta-Analyses
by: Amine Souadka, et al.
Published: (2022-05-01)

A Nomogram for Preoperative Prediction of the Risk of Lymph Node Metastasis in Patients with Epithelial Ovarian Cancer
by: Huiling Xiang, et al.
Published: (2023-03-01)